TMCnet News
Hot Stock: Idenix Pharmaceuticals, Shares Gain 5.2% (IDIX)Jan 24, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Idenix Pharmaceuticals (NASDAQ:IDIX) is one of today's best performing low-priced stocks, up 5.2% to $4.62 on 1.2x average daily volume. Thus far today, Idenix Pharmaceuticals has traded 1.2 million shares, vs. average volume of 992,000 shares per day. The stock has outperformed the Dow (5.2% to the Dow's 0.6%) and outperformed the S&P 500 (5.2% to the S&P's 0.3%) during today's trading. Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV). Idenix Pharmaceuticals has overhead space with shares priced $4.62, or 30.0% below the average consensus analyst price target of $6.60. The stock should find initial resistance at its 50-day moving average (MA) of $4.86 and further resistance at its 200-day MA of $6.82. Over the past year, Idenix Pharmaceuticals has traded in a range of $3.35 to $15.25 and is now at $4.62, 38% above that low. The 200-day and 50-day moving averages have moved 0.76% lower and 0.37% higher over the past week, respectively. SmarTrend is tracking the current trend status for Idenix Pharmaceuticals and will alert subscribers who have IDIX in their portfolio or watchlist when shares have changed trend direction. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |